Exklusiver Live-Stream direkt von der World of Trading - 2 Tage mit einzigartigen Themen und Experten. Kostenlos teilnehmen + Videos erhalten. -w-
16.01.2017 23:57:00

Neurovascular Intervention Market (by Device Category, Disease Segment, Country Wise and Company) and Forecast to 2021 - Global Analysis

LONDON, Jan. 16, 2017 /PRNewswire/ -- The global neurovascular intervention market is poised to reach nearly US$ 4 Billion by 2021. The market growth is attributed to factors such as an increased adoption of neurovascular devices, ageing population, rising prevalence of cerebrovascular diseases, technological advancements and deal making activity globally. However, the factors such as regulatory standards and compliance, unmet needs and a dearth of skilled neurosurgeons are restraining the growth of neurovascular interventional market.

By Device Category Neurovascular Intervention Market Analysis -

In terms of device category, Coil represents the largest market for neurovascular intervention controlling XX% share in 2015. Coil segment is facing increased competition from the emerging Carotid Stent, Micro wire/Catheter and Clot Removal device. The increasing adoption of emerging technologies such as flow diverters is likely to take market share away from the stent-assisted and balloon-assisted coiling markets. The coil assist balloon captured smallest share of the neurovascular intervention market.

By Disease Segment Neurovascular Intervention Market Analysis - Aneurysm disease segment accounts for the largest share of the global neurovascular intervention market. Arteriovenous Malformation (AVM) captures the second largest share of the total neurovascular intervention market, being followed by ischemic stroke. Intracranial atherosclerotic disease (ICAD) captured least share of the neurovascular intervention market.

Neurovascular Intervention Market Country Analysis - United States is at the forefront of neurovascular intervention market, and is likely to remain the leader throughout the forecasting period. Japan is the second leading market for neurovascular intervention being followed by China. In European region, Germany and France are leading the way in neurovascular intervention market and are competing closely with each other to grab maximum share of the pie. In Latin American countries, Brazil accounted for XX% share of the global neurovascular intervention market in 2015. Italy, Spain, United Kingdom and India represents a major market growth area.

Neurovascular Intervention Market Company Analysis - Medtronic and Stryker dominated the global neurovascular intervention market. They together accounted for over 45% share of the global neurovascular intervention market in 2015. DePuy Synthes captured third highest share of the total neurovascular intervention market in 2015, while Terumo Corporation and Penumbra Inc. are competing closely with each other to capture maximum share of the pie.

iGATE RESEARCH report titled "Neurovascular Intervention Market (by Device Category, Disease Segment, Country Wise and Company) and Forecast to 2021 - Global Analysis" provides a comprehensive assessment of the fast-evolving, high-growth global neurovascular intervention market. This report covers various aspects of the neurovascular intervention market including Device Category, Disease Segment, Country Wise Market, Company Sales and Product Portfolio Analysis, Competitive Landscape of Major Neurovascular Companies, and the Growth Drivers and Challenges influencing global neurovascular intervention market.

This 124 Page report with 61 Figures and 10 Tables has been analyzed from 8 viewpoints:

1. By Device Category - Global Neurovascular Intervention Market and Forecast (2009 - 2021)
2. By Disease Segment - Global Neurovascular Intervention Market and Forecast (2010 - 2021)
3. By Country - Neurovascular Intervention Market and Forecast (2013 - 2021)
4. Global Neurovascular Intervention Market - Company Analysis
5. Neurovascular Intervention Market - Major Deals
6. Neurovascular Intervention Market - Major Products Approval Status
7. Competitive Landscape of Major Neurovascular Companies
8. Neurovascular Intervention Market - Driving Factors and Challenges

Global Neurovascular Intervention Market and Forecast - 8 Device Category Analysis

1. Coil
2. Carotid Stent
3. Clot Removal Device
4. Liquid Embolic
5. Coil Assist Balloon
6. Coil Assist Stent
7. Flow Diverter Stent
8. Micro wire/Catheter

Global Neurovascular Intervention Market and Forecast - 4 Disease Segment Analysis

1. Aneurysm
2. Intracranial atherosclerotic disease (ICAD)
3. Ischemic Stroke
4. Arteriovenous Malformation (AVM)

Neurovascular Intervention Market and Forecast - 10 Countries Analysis

1. United States
2. Germany
3. France
4. Italy
5. Spain
6. UK
7. Japan
8. China
9. India
10. Brazil

Global Neurovascular Intervention Market and Forecast - 6 Companies Analysis

1. Stryker
2. Medtronic
3. Terumo Corporation
4. DePuy Synthes
5. Penumbra Inc.
6. Others

Research Methodologies

Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.

Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.


Download the full report: https://www.reportbuyer.com/product/4214613/

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com  
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/neurovascular-intervention-market-by-device-category-disease-segment-country-wise-and-company-and-forecast-to-2021---global-analysis-300391564.html

SOURCE ReportBuyer

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!